Tiankang Biotech: 2024 Financial Results Report
Tiankang Biology: Self-inspection form for the implementation of internal control rules
Tiankang Biology: Goodwill Impairment Test Report
Tiankang Biology: 2025 Financial Budget Report
Tiankang Biology: Report on the evaluation of the performance of accounting firms in 2024 and the performance of supervisory duties by the Audit Committee
Tiankang Biotech: Announcement on preparations for the 2024 inventory price reduction
Tiankang Biotech: Notice of Annual General Meeting of Shareholders
Tiankang Biotech: Announcement on signing a tripartite supervisory agreement on fund-raising
Tiankang Biology: Legal Opinion on the 2025 First Extraordinary General Meeting of Shareholders of Tiankang Biotech Co., Ltd.
Tiankang Biotech: Announcement of Resolutions of the 2025 First Extraordinary General Meeting of Shareholders
Tiankang Biotech: Announcement on changing the implementation location and implementing entity of some fund-raising projects
Tiankang Biotech: Announcement on Launching Commodity Futures Hedging Business
Tiankang Biotech: Notice on Convening the First Extraordinary General Meeting of Shareholders in 2025
Tiankang Biotech: Announcement of Resolutions of the 6th Extraordinary General Meeting of Shareholders in 2024
Tiankang Biology: Legal Opinion on the 2024 6th Extraordinary General Meeting of Shareholders of Tiankang Biotech Co., Ltd.
Tiankang Biotech: An indicative announcement regarding the holding subsidiary\'s intention to apply for a public offering of shares to unspecified qualified investors and listing on the Beijing Stock Exchange
Tiankang Biotech: Notice on Convening the 6th Extraordinary General Meeting of Shareholders in 2024
Tiankang Biotech: Announcement on the progress of capital increase to wholly-owned subsidiaries through debt-for-equity swaps
Tiankang Biology: Legal Opinion on the 5th Extraordinary General Meeting of Shareholders of Tiankang Biotech Co., Ltd. in 2024
Tiankang Biotech: Announcement of Resolutions of the Fifth Extraordinary General Meeting of Shareholders in 2024